INS and Hypoglycemia: In recent years, there were always debates on the detrimental effect of SU in diabetic patients, including its possible CV morbidity and mortality;[13,14] some studies suggested avoiding the use of SU in diabetes treatment, especially after insulin initiation.[15] Both insulin and SU had the propensities of hypoglycemia, body weight increase and possibly CV injury.